Earnings Feed
Start Free
Home/Filings/3/0000899243-20-018149
3//SEC Filing

Nutritional Health LTP Fund General Partner LLC 3

Accession 0000899243-20-018149

CIK 0001694665other
View on SEC.govCompany Profile

Filed

Jun 30, 8:00 PM ET

Accepted

Jul 1, 5:21 PM ET

Size

11.4 KB

Accession

0000899243-20-018149

Insider Transaction Report

Form 3
Period: 2020-06-29
Evelo Biosciences, Inc.EVLO
Nutritional Health LTP Fund General Partner LLC
10% Owner
Holdings

  • Common Stock

    (indirect: See Footnote)
    2,645,637

  • Common Stock

    (indirect: See Footnote)
    1,333,333
Flagship Pioneering, LLC
10% Owner
Holdings

  • Common Stock

    (indirect: See Footnote)
    1,333,333

  • Common Stock

    (indirect: See Footnote)
    2,645,637
Flagship VentureLabs V Manager LLC
10% Owner
Holdings

  • Common Stock

    (indirect: See Footnote)
    1,333,333

  • Common Stock

    (indirect: See Footnote)
    2,645,637
Nutritional Health LTP Fund, L.P.
10% Owner
Holdings

  • Common Stock

    (indirect: See Footnote)
    2,645,637

  • Common Stock

    (indirect: See Footnote)
    1,333,333
Footnotes (3)
  • [F1]On June 29, 2020, Nutritional Health LTP Fund, L.P. ("Nutritional LTP") acquired 1,333,333 shares pursuant to an underwritten public offering of common stock of the Issuer.
  • [F2]Shares held by Nutritional LTP. Nutritional Health LTP Fund General Partner LLC ("Nutritional LTP GP") is the general partner of Nutritional LTP. Noubar B. Afeyan Ph.D. ("Dr. Afeyan") is the sole member and manager of Nutritional LTP GP. Each of the reporting persons except for Nutritional LTP disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.
  • [F3]Shares held by Flagship VentureLabs V LLC ("VentureLabs V"). Flagship VentureLabs V Manager LLC ("VentureLabs V Manager") now serves as manager of VentureLabs V. Flagship Pioneering, Inc. ("Flagship Pioneering") is the manager of VentureLabs V Manager. Dr. Afeyan serves as sole director of Flagship Pioneering. Each of the reporting persons except for VentureLabs V disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein. As a result in the change of the manager of VentureLabs V, VentureLabs V Manager and Flagship Pioneering are now reporting persons under Section 16 with respect to the shares of the Issuer held directly by VentureLabs V.

Documents

1 file

Issuer

Evelo Biosciences, Inc.

CIK 0001694665

→
Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001780951

Filing Metadata

Form type
3
Filed
Jun 30, 8:00 PM ET
Accepted
Jul 1, 5:21 PM ET
Size
11.4 KB
View on SEC.gov